Cytoplasmic immunoglobulin content in multiple myeloma.
Bone marrow cells of 82 patients with multiple myeloma were subjected to flow cytometric analysis of DNA and cytoplasmic immunoglobulin (CIg) content using propidium iodide and direct immunofluorescence assays. Except for two patients with nonsecretory myeloma, there was conformity in the immunoglobulin type derived from immunoelectrophoresis and plasma cell CIg staining. One patient with nonsecretory myeloma exhibited monotypic CIg staining, while the second showed no reaction. In eight patients with IgG lambda myeloma, the same tumor cells contained both lambda and kappa light chains, suggesting the productive rearrangement of both light chain genes. 14 patients with previously unrecognized plasma cells of low RNA content, all of whom were resistant to chemotherapy, were identified by CIg staining. By revealing previously unrecognized plasma cells with low RNA content, CIg analysis identified more patients with treatment-refractory myeloma.
B
B
Barlogie
R
R
Alexanian
M
M
Pershouse
L
L
Smallwood
L
L
Smith
D001854:Bone Marrow Cells; D003593:Cytoplasm / Q000032:analysis*; D004247:DNA / Q000032:analysis; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D007146:Immunoglobulin lambda-Chains / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D009101:Multiple Myeloma / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D011419:Propidium; D012313:RNA / Q000032:analysis
D007074:Immunoglobulin G; D007146:Immunoglobulin lambda-Chains; D007136:Immunoglobulins; D011419:Propidium; D012313:RNA; D004247:DNA